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Exogenous EGF and BDNF treatment enhances differentiation
and proliferation of cultured taste cells
Mehmet Hakan ÖZDENER1,2, Nancy Ellen RAWSON1

Aim: To determine the effects of epidermal growth factor (EGF) and brain-derived neurotrophic factor (BDNF) on
taste cell generation by utilizing a long-term rat taste cell culture that exhibits molecular and functional characteristics
of mature taste cells. The role of neurotrophic factors in taste cell development is not well understood.
Materials and methods: A long-term rat taste cell culture exhibiting molecular and functional characteristics of
mature taste cells was used. The effects of 3 different concentrations of EGF and BDNF on taste cell differentiation and
proliferation were examined at 3 different time points.
Results: We showed the presence of BDNF, EGF receptor, and Trk-B immunoreactivity in subsets of cultured taste
cells in vitro. EGF at 10 ng/mL increased the proliferation rate of cultured rat taste cells in 1- and 2-week-old cells. No
treatment altered the proliferation rate at 4 weeks. Staining with bromodeoxyuridine (BrdU) and gustducin antibodies
demonstrated differentiation in a subset of taste cells, indicating that a 10-ng concentration each of EGF and BDNF
increased BrdU and gustducin immunoreactive cell numbers at 1 and 2 weeks.
Conclusion: Our data suggest that EGF and BDNF induced not only taste cell proliferation but also differentiation
without requiring nerve innervation.
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Introduction
Taste receptor cells are a highly specialized, heterogeneous population with unique histological,
molecular, and physiological characteristics. While much is known about the biological and
behavioral basis of taste, comparatively less is understood about the factors governing proliferation
and differentiation of taste receptor cells. There are presently 2 models to explain the development
of taste cells. The neural induction model postulates that peripheral nerve fibers induce taste bud
formation (1,2). Consistent with this, studies of lingual explants and tongue cultures show that
denervated mammalian tongues failed to form taste buds, indicating that the structural integrity of
the mammalian taste bud is apparently dependent upon the presence of gustatory nerves (cranial
nerves VII, IX, and X) (1-5). In another study, damaging cranial nerve IX (the glossopharyngeal
nerve) resulted in reduced expression of taste cell markers such as T1R3, gustducin, Mash1, shh,
and Nkx2.2 (6-8). Alternatively, according to the early specification model, taste cells may arise
from multiple progenitors of the local ecto- or endodermal epithelium of the oropharynx in the
absence of innervation (9-12). The role of factors governing proliferation and differentiation of
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taste receptor cells is less understood. Neurotrophins
may serve as local trophic factors for the embryonic
growth of nerve fibers to induce differentiation of the
taste buds (13,14). Brain-derived neurotrophic factor
(BDNF) and epidermal growth factor (EGF) are
among a number of trophic factors implicated in taste
bud development, and BDNF and epithelial growth
factor receptor (EGFR) expression were seen in taste
buds and gustatory papillae in humans (15-17). In a
study of embryonic tongue culture, treatment with
EGF resulted in epithelial cell proliferation between
papillae, but it decreased papillae formation by
inducing activation of EGFR followed by induced
PI3K/Akt, MEK/ERK, and p38 MAPK signaling
pathways (18). BDNF mRNA is expressed in early
developing taste papillae and is essential during
embryonic initiation and the maintenance of gustatory
innervation of taste buds (19-22). Recently it was
shown that BDNF produced in peripheral target cells
regulates the survival of early geniculate neurons by
inhibiting the cell death of differentiated neurons on
E13.5 of development (22). In another study, BDNF
(-/-) knockout mice showed a significant reduction
in geniculate neurons innervating the tongue, clearly
indicating the role of BDNF (23). EGF also appears
essential for the normal development of the anterior
gustatory epithelia, as both EGF/BDNF knockout
and EGF knockout mice exhibit impaired fungiform
taste papillae (24). EGF has also been implicated in
the proliferation of oral epithelia and appears to play a
role in normal taste bud maintenance (25). This role is
supported by the observation that EGF was sufficient
to reverse the loss of normal fungiform papillae
morphology and taste buds following the removal of
submandibular and sublingual salivary glands (26).
Results from our initial study generated an in
vitro culture system that can be used to maintain rat
primary taste cells for more than 2 months (27). In
the current study, we utilized this model system to
examine the role of exogenous BDNF and EGF on
the proliferation/differentiation and physiological
properties of cultured rat taste cells. Our results
indicate that while exogenous EGF (10 ng/mL)
induced proliferation and differentiation, BDNF
(10 ng/mL) reduced proliferation in a dose-related
manner but increased molecular and functional
indicators of differentiation of cultured rat taste cells
at 1 and 2 weeks.
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Materials and methods
Animal subjects
Sprague Dawley rats, aged 4 to 8 weeks, were purchased
from Charles River Laboratories (Wilmington, MA,
USA) and housed individually under 12-h light/dark
cycles. The rats were given food and water ad libitum.
The numbers of animals used were the minimum
required to accomplish the goals of this study. All
treatment and surgical procedures were conducted
in accordance with the Public Health Service Policy
on Humane Care and Use of Laboratory Animals.
The use and handling of animals was approved by the
Monell Chemical Senses Center Institutional Animal
Care and Use Committee and was in accordance with
the National Institutes of Health Guide for the Care
and Use of Laboratory Animals.
Primary cell culture
A long-term rat taste cell culture was established
according to previously described protocols (27).
Briefly, dissected rat tongue was placed immediately
into an isolation solution for 5-10 min on ice.
The preparation was then removed from ice, and
approximately 1 mL of the isolation buffer mixed
with 1.5 mg/mL pronase E (Sigma, St. Louis, MO,
USA) and 1 mg/mL elastase (Sigma) was injected
uniformly with a 25-gauge NORM-JECT syringe
(Restek Corporation, Bellefonte, PA, USA) under and
around the lingual epithelium of the circumvallate
and foliate papillae of the dissected tongue. After
30 min of incubation in the isolation buffer at room
temperature, the epithelium was gently peeled from
the underlying muscle layer under a dissecting
microscope (Stereomaster, Fischer Scientific,
Pittsburgh, PA, USA) and placed in more isolation
solution. The isolated epithelium was transferred to
Iscove’s modified Dulbecco’s medium (Gibco BRL,
New York, NY, USA) containing 10% fetal bovine
serum (FBS; BTI, Stoughton, MA, USA) and MCDB
153 medium (Sigma) at a ratio of 1:5. It was then
cut into small pieces with a razor blade. The pieces
were seeded onto glass coverslips (Fisher Scientific)
coated with rat tail collagen type 1 (diluted 1:4 in
distilled nuclease-free water; BD Sciences, San Diego,
CA, USA) and incubated at 36 °C in a humidified
environment containing 5% CO2. Culture medium
was replaced after 48 h and then every 5-7 days. Prior
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to use, coverslips were treated with 2 M NaOH for 1
h and left overnight in 70% nitric acid (HNO3). After
1 h in HCl acid wash, the coverslips were autoclaved
in water, rinsed with 70% ethanol and 100% ethanol,
and air dried.

USA) according to the manufacturer’s protocol. The
statistical significance of the doubling rate between
the groups was determined by one-way ANOVA and
Tukey’s test using the StatMostTM software program
(Dataxiom Software Inc., Los Angeles, CA, USA).

Treatment of cultured taste cells with EGF and
BDNF

Immunohistochemistry of rat tongue foliate papilla

Taste cells were cultured and maintained as described
above. Rat taste cells were cultured for 1, 2, and 4
weeks, and then EGF (01-101, Upstate Biotechnology,
Lake Placid, NY, USA) and BDNF (01-194, Upstate
Biotechnology) were added, either individually or
in combination, exogenously into tissue culture
medium for 5 days at 3 different concentrations (1,
10, and 100 ng/mL). During this period, if cells were
used for the determination of gustducin expression,
taste cells were also labeled with BrdU as described
below. Cultured taste cells were tested at 5 days after
plating. Immunostaining of EGF- and BDNF-treated
cultured cells were analyzed as described below.
Determination of cellular proliferation: WST-1
proliferation assay
Cellular proliferation was assessed using the reagent
WST-1 cell proliferation kit (Chemicon, Billerica,
MA, USA). This colorimetric assay measures the
metabolic activity of viable cells based on the
cleavage of the tetrazolium salt WST-1 into formazan
by mitochondrial dehydrogenase in live cells (28).
Primary taste cells were plated in a 96-well plate and
maintained until the time indicated for exogenous
treatment. Cells were treated with EGF, BDNF, or a
combination of the 2 (EGF+BDNF) at the indicated
concentrations (0, 1, and 10 ng/mL) for 5 days. This
was followed by incubation with WST-1 reagent at a
dilution of 1:10 in the original conditioned media for
4 h. After thorough shaking for 1 min, the formazan
produced by the metabolically active cells in each
sample was measured at a wavelength of 450 nm
with a plate reader (ICN Multiscan MCC/340, MKI;
ICN Biomedicals GmbH, Meckenheim, Germany).
Absorbance readings were normalized against control
wells containing medium only. In order to optimize
the differences in each well and to compare each
of the conditions, total protein concentration was
estimated for each well using the Bio-Rad DC Protein
Estimation Kit (Bio-Rad Laboratories, Hercules, CA,

Rats were euthanized by CO2 inhalation followed
by cervical dislocation. The tongue was dissected
proximal to the circumvallate papillae and close to the
foliate papillae region, then immediately placed into
4% paraformaldehyde in 0.1 M phosphate buffered
saline (PBS; pH 7.2) for 1 h at room temperature.
After washing 3 times with PBS, tissue was placed
in 10%, 20%, and 30% sucrose solutions, each for
24 h at 4 °C for cryoprotection. The tissues were
rapidly frozen in M-1 embedding matrix (Shandon
Lipshaw, Pittsburgh, PA, USA) in a dry-ice acetone
bath. Sections were cut horizontally at a thickness
of 8 μm through the entire foliate papillae and
serially mounted onto SuperFrost Plus slides (Fisher
Scientific) with 4 sections per slide. Slides were stored
in slide boxes at either −30 or −80 °C prior to use.
After being maintained at 40 °C for 1 h, tissues were
initially treated with H2O2 solution (4 mL PBS + 0.5
mL 100% methanol + 0.5 mL 30% H2O2) for 20 min
to block endogenous peroxidase. Tissues were then
blocked with 0.3% Triton X-100, 4% normal goat
serum, and 3% bovine serum albumin in PBS for 1 h.
The primary antibodies, polyclonal rabbit anti-Trk-B
(1:250, sc-12; Santa Cruz Biotechnology, Santa Cruz,
CA, USA; raised against a peptide corresponding
to the C-terminal cytoplasmic domain of mouse
Trk-B) or polyclonal rabbit anti-EGFR (1:250, sc-03;
Santa Cruz Biotechnology; raised against a peptide
corresponding to the C-terminus of EGFR of human
origin), were diluted in blocking solution, added to
the tissue-covered slides, and incubated overnight
at 4 °C in a humidified chamber. After washing 3
times with PBS for 15 min, the tissues were reacted
in the dark with goat antirabbit Alexa 633 for Trk-B
and EGFR (1:500; Molecular Probes Inc., Eugene,
OR, USA) and diluted in blocking buffer for 30
min at room temperature in a humidified chamber.
The slides received 3 PBS washes of 15 min each
followed by 3 washes with water of 10 min each
prior to mounting with VECTASHIELD with DAPI
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(Vector Labs, Burlingame, CA, USA). Controls
for immunofluorescence consisted of omitting
the primary antibody (only using the secondary
antibody) and substituting with nonimmune serum
appropriate for the primary antibody.
BrdU labeling and immunocytochemistry
In order to determine the relationship between
proliferation/differentiation and expression of
Trk-B and EGFR in primary cultured taste cells,
we examined the expression of Trk-B and EGFR
immunocytochemically in both 9-day-old and
2-month-old cultures. To determine whether
proliferating cells expressed these growth factors
or receptors, cells were treated with BrdU. For
immunofluorescence double-labeling, isolated taste
cells were seeded onto collagen-coated coverslips,
maintained for the indicated time, and treated with
50 μM BrdU (Sigma) dissolved in DMSO (Sigma)
for 48 h. BrdU was then replaced with fresh medium.
The BrdU-treated cells were maintained for 3
additional days in culture and were then fixed with
4% paraformaldehyde in PBS (pH 7.2) for 10 min at
room temperature. After washing in PBS, the cells
were treated with H2O2 solution for 20 min to block
endogenous peroxidase and then denatured with 2 N
HCl at 37 °C for 30 min. SuperBlock blocking buffer
in PBS (Pierce Chemical Company, Rockford, IL,
USA) was used to reduce nonspecific binding. Cells
were then incubated overnight at 4 °C with mouse
anti-BrdU (dilution 1:100; Sigma B-2531) diluted in
10% SuperBlock with 0.05% Tween 20. Alexa Fluor
488 conjugated antimouse IgG (1:500; Molecular
Probes Inc.) diluted in 10% SuperBlock with
0.05% Tween 20 was used for immunofluorescence
detection. Coverslips were thoroughly washed with
PBS and then reblocked with 0.3% Triton X-100, 4%
normal goat serum, and 3% bovine serum albumin
in PBS and incubated with either polyclonal rabbit
anti-Trk-B or polyclonal rabbit anti-EGFR (1:250)
overnight at 4 °C. After washing with PBS, cells were
incubated with Alexa Fluor 633 goat antirabbit-IgG
(1:500; Molecular Probes Inc.) diluted in blocking
buffer for 1 h. After washing in PBS and water,
coverslips were mounted with VECTASHIELD
(Vector Laboratories). To determine the specificity of
staining, controls for immunofluorescence consisted
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of omitting the primary antibody or substituting
the primary antibody with the host IgG from which
the antibody was generated. Controls for doublelabeling experiments involved omitting either the
first or second primary antibody while maintaining
all other steps in the protocol to check for nonspecific
interactions. In all cases, these controls revealed
no artifactual labeling. Immunoreactive cells were
counted in at least 3 fields at 20× magnification.
Confocal imaging
Fluorescent images were captured with a Leica
TCS SP2 spectral confocal microscope (Leica
Microsystems Inc., Mannheim, Germany) using UV,
argon, and HeNe lasers and a HC PL APO CS 20.0×
(0.070 NA) objective. The excitation wavelengths
used were at 405 nm for DAPI, 488 nm for Alexa Fluor
488, and 633 nm for Alexa Fluor 633, with emissions
detected at appropriate wavelengths. The pinhole
diameter was set at the first minimum diameter of
the Airy disk for the objective used, which provided
acceptable resolution of the z-axis for the fluorescent
focal plane. Laser power and photomultiplier gain
were adjusted for an optimal signal-to-noise ratio
and held constant for comparison of antibodylabeled and control slides. Sequential acquisition of
each wavelength was used for some double-labeling
experiments to prevent crosstalk or bleed-through
between fluorophores. Leica Scanware software
was used to acquire confocal images, scanning
unidirectionally with a 1024 × 1024 pixel format with
3 lines and 2 frames on average. Computer-controlled
digital zoom was used to increase magnification to
a maximum of 2.3× with the 20× objective. Images
were arranged and minimally adjusted for contrast
and brightness using LCS software (Leica) and
Adobe Photoshop Elements 2.0 (Adobe Systems Inc.,
San Jose, CA, USA).
Western blot
Western blots were conducted using standard
immunoblotting techniques (29). Cultured primary
rat taste cells were lysed in RIPA buffer (150 mM
NaCl, 10 mM Tris, pH 7.2, 0.1% sodium dodecyl
sulfate (SDS), 1% Triton X-100, 1% deoxycholate, 5
mM EDTA) containing protease inhibitors. Protein
concentration was estimated for each sample using
the Bio-Rad DC Protein Estimation Kit (Bio-Rad
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Laboratories) according to the manufacturer’s
protocol. Protein samples were mixed with SDS
loading buffer containing β-mercaptoethanol; the
mixture was boiled for 5 min and then placed on
ice for 5 min. The cellular lysates were separated by
SDS-polyacrylamide (5%-15%) gradient gel (BioRad Laboratories) electrophoresis and transferred
to a polyvinylidene fluoride membrane (Bio-Rad
Laboratories) that was then incubated at 4 °C
overnight with 1% nonfat dry milk. Polyclonal rabbit
anti-Trk-B (1:250; Santa Cruz Biotechnology) and
polyclonal rabbit anti-EGFR (1:250; Santa Cruz
Biotechnology) were used to identify taste cell
proteins. After 1.5 h of incubation with primary
antibodies at room temperature, the membrane
received 3 washes of 15 min each in PBS with
0.05% Tween-20 (PBS/T). It was then reacted with
horseradish peroxidase (HRP)-conjugated secondary
antirabbit antibody (NA934, 1:5000; Amersham
Biosciences, Piscataway, NJ, USA) for 1 h at room
temperature, followed by 3 washes of 15 min each
with PBS/T. Signals were detected with the enhanced
chemiluminescence (ECL) immunoblot detection
system (Amersham Biosciences) following the
manufacturer’s instructions. X-ray films were later
scanned for documentation and analysis.
Statistics
Results are expressed as means ± SE calculated from
3 independent experiments per group. Comparisons
between control and treatment groups were
performed by 2-way ANOVA (StatMostTM software
program, Dataxiom Software Inc.) followed by
Tukey’s test. P < 0.05 was considered significant.
Results
Expression of Trk-B and EGFR in rat foliate papillae
and cultured rat taste cells
To explore the effects of neurotrophic factors that may
be involved in taste cell generation, we examined the
expression of several molecules previously implicated
in this process (24,30-32). Immunohistochemical and
immunocytochemical experiments were performed
to determine the presence of EGFR and Trk-B in rat
foliate papillae tissue and cultured rat taste cells aged
9 days or 2 months. Immunoreactivity for EGFR or

Trk-B was detected in cells within the foliate papilla
of rat tongue (Figures 1A and 1B, respectively). The
Trk-B antibodies immunolabeled subsets of cells
within the cultures at 9 days and after 2 months
(Figures 1C and 1D, and 1E and 1F, respectively).
We also observed EGFR immunoreactivity in the
cultured taste cells at 9 days and after 2 months
(Figures 1G and 1H, and 1I and 1J, respectively).
The staining patterns observed in rat tongue tissue
were consistent with those reported in the literature
(24,26,31,33,34).
We utilized cultured rat foliate and circumvallate
taste cells cultured for 9 days to determine whether
cells expressed EGFR and Trk-B. Western blot
analysis of cultured rat taste cells obtained from rat
circumvallate and foliate papillae identified bands of
the appropriate size, indicating expression of EGFR
and Trk-B, albeit at apparently different levels of
expression (these were not quantified) (Figure 1K).
Expression of Trk-B and EGFR proteins in a subset
of newly divided cultured taste cells
Immunocytochemical experiments were performed
to determine whether cells expressing Trk-B or
EGF-R were actively dividing or differentiated. Taste
cell proliferation was demonstrated by labeling with
BrdU. Immunocytochemical experiments showed
that a subset of BrdU-labeled cells also exhibited
EGFR or Trk-B immunoreactivity in the 9-day-old
and 2-month-old cultures (Figure 2). Approximately
30% of cells were labeled with BrdU after 9 days in
culture, indicating cellular proliferation (Table 1). A
subset of these cells were immunoreactive for both
Trk-B and BrdU (approximately 20%-25% of all
cells), while approximately 10% and 20% of cells were
labeled selectively with either BrdU or Trk-B (Figures
2A-2D). After 2 months, the presence of BrdUimmunoreactive cells decreased to 10% of the total
cells, suggesting a decline in proliferation with time
(Figures 2I-2L). A subset of 2-month-old cells was
successfully labeled with either Trk-B (7%-10%) or
BrdU + Trk-B antibodies (5%-7%), indicating that at
least some newly generated cells could be responsive
to BDNF.
We observed similar results using EGFR antibody
in cells labeled with BrdU at 9 days and 2 months
of age. BrdU-treated 9-day-old taste cells showed
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Figure 1. EGFR and Trk-B immunoreactivity in taste papillae and taste cells in culture: A) EGFR and B) Trk-B immunoreactivity
in rat taste bud cells from foliate papillae; C) bright-field and D) immunofluorescence images of cultured taste
cells immunostained for Trk-B at 9 days; E) bright-field and F) immunofluorescence images of cultured taste cells
immunostained for Trk-B at 2 months; G) bright-field and H) immunofluorescence images of cultured taste cells
immunostained for EGFR at 9 days; ; I) bright-field and J) immunofluorescence images of cultured taste cells
immunostained for EGFR at 2 months; nuclei were stained with DAPI (blue); scale bar = 30 μm. K) Western blot
analysis indicating the presence of Trk-B and EGFR expression at the expected size in cultured taste cells.

immunoreactivity to both EGFR and BrdU (20%)
(Figures 2E-2H). Approximately 15% of cells in
these cultures were immunoreactive only to EGFR,
while less than 1% of cells were labeled only with
BrdU, indicating that almost all newly generated
cells were EGFR positive. BrdU labeling was lower in
2-month-old cultured taste cells, approximately 10%
of the total cells, suggesting a decline in proliferation
with time. A subset of 2-month-old cells showed
immunoreactivity with either EGFR alone (<1%)
or BrdU alone (4%-5%). Double-labeling of BrdU
and EGFR antibodies produced 5% positive cells,
indicating that about 50% of the newly generated
cells could be responsive to EGF (Figures 2M-2P).
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These results showed that double-labeling of either
Trk-B or EGFR with BrdU provides approximately
25% positive staining at 9 days and 5% at 2 months.
Some cultured cells were immunoreactive to a
single biomarker only, and many cells were not
immunolabeled with any of these antibodies. The
proportion of double-labeled cells relative to total
BrdU-labeled cells was comparable at both time
points. This indicates that a quantitative decline
in growth occurs over this time frame in culture,
although some cells with the potential to respond to
neurotrophic factors persist.
The specificity of immunostaining was evaluated
in a variety of control experiments. No cross-reactivity
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Figure 2. Immunocytochemical experiments demonstrated that a subset of BrdU immunoreactive cells also exhibited EGFR
or Trk-B immunoreactivity in the 9-day-old and 2-month-old cultures. A subset of cells treated with BrdU was
immunoreactive for both Trk-B (red) and BrdU (green) in both 9-day-old (Figures 2A-2D) and 2-month-old (Figures
2I-2L) cultures. Similarly, EGFR immunostained a subset of BrdU-labeled cells in both younger and older cultures.
BrdU-treated 9-day-old and 2-month-old taste cells showed immunoreactivity to both EGFR (Figures 2E-2H) and
BrdU (Figures 2M-2P). Scale bar = 30 μm.
Table 1. Counts of in vitro-generated taste cells expressing receptors for EGF and BDNF.
Nine-day-old cells (n = 200)
EGFR +
EGFR −
EGFR +
Trk-B +
Trk-B Trk-B +

BrdU +
BrdU +
BrdU –
BrdU +
BrdU +
BrdU –

20%
<1%
10%-20%
20%-25%
5%-10%
20%

Two-month-old cells (n = 140)
EGFR +
EGFR −
EGFR +
Trk-B +
Trk-B −
Trk-B +

BrdU +
BrdU +
BrdU –
BrdU +
BrdU +
BrdU –

5%
4%-5%
<1%
5%-7%
3%
7%-10%
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Determination of taste cell proliferation after
treatment with EGF and BDNF
Effects of EGF and BDNF on cellular proliferation of
1-week-old cultured taste cells
In 1-week-old cultured taste cells (Figure 3A), EGF
at 10 ng/mL showed significant effects on cellular
proliferation compared with the control (0 ng/mL),
1 ng/mL, and 100 ng/mL treatments (P = 2 × 10–6,

Percentage of cells counted

Percentage of cells counted

with the secondary antibody (Alexa 633) was detected
when the BrdU-reacted cells were further processed in
the absence of the second primary antibody. Cells not
exposed to BrdU showed no BrdU immunoreactivity,
demonstrating the specificity of the BrdU antibody
(data not shown). Immunostaining with antibody
specific immunoglobulin did not indicate nonspecific
immunoreactivity (data not shown).
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Figure 3. EGF and BDNF modulation of taste cell proliferation in culture is dose- and age-dependent. In 1-week-old cultures (Figure
3A), EGF at 10 ng/mL showed significant stimulatory effects on cellular proliferation compared with other groups. BDNF
treatment dose-dependently inhibited cellular proliferation. The addition of EGF did not attenuate the antiproliferative effect
of BDNF. In 2-week-old cultures (Figure 3B), EGF-treated cells showed patterns similar to those of the 1-week-old cells. BDNF
at 100 ng/mL significantly inhibited cellular proliferation compared with the other groups. Treatment with EGF+BDNF did
not show any proliferative effect at any doses compared to the control; however, treatment with both factors at 1 and 100 ng/
mL resulted in reduced cellular proliferation. In 4-week-old cultures (Figure 3C), there were no significant effects of EGF
alone or in combination with BDNF on proliferation compared with the control. As in younger cells, treatment with BDNF
alone at 1 and 100 ng/mL significantly suppressed proliferation of cultured taste cells compared with untreated cells.
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dfn = 3, dfd = 12). BDNF treatment exhibited an
antiproliferative effect, which was significant at 100 ng/
mL compared to other groups (P = 7 × 10–7). Although
there was no difference between the control and
treatment groups at 1 ng/mL and 10 ng/mL, there
was a significant difference between the treatment
groups (P = 7 × 10–7). Combined treatment with
EGF+BDNF at 100 ng/mL reduced proliferation
relative to the control or 10 ng/mL, but not 1 ng/mL,
suggesting a reverse U-shaped dose relationship (P =
4 × 10–5).
Effects of EGF and BDNF on proliferation of
2-week-old cultured taste cells
At 2 weeks, EGF-treated cells showed patterns
similar to those of the 1-week-old cells. A significant
proliferative effect was elicited by 10 ng/mL EGF,
while there was no significant difference between 1
ng/mL and 100 ng/mL and the control (P = 4 × 10–5,
dfn = 3, dfd = 12). In BDNF-treated cells, 1 ng/mL
and 10 ng/mL induced cellular proliferation slightly,
but not significantly, compared with the untreated
cells. Proliferation was significantly reduced by
treatment with BDNF at 100 ng/mL compared to
treatment with 1 ng/mL, 10 ng/mL, and the control
(P = 8 × 10–6). In contrast to results for 1-week-old
cells, treatment with EGF+BDNF did not promote
proliferation at any dose compared to the control;
however, cells treated with 1 ng/mL and 100 ng/
mL exhibited significantly less proliferation than
untreated cells (P = 0.0003).
Effects of EGF and BDNF on cellular proliferation
of 4-week-old cultured taste cells
There were no significant effects of EGF treatment
on cellular proliferation compared with untreated
control cells cultured for 4 weeks. Treatment with
BDNF at 1 ng/mL and 100 ng/mL significantly
suppressed proliferation of cultured taste cells
compared with untreated cells (P = 3 × 10–6, dfn =
3, dfd = 12), while treatment with 10 ng/mL BDNF
did not affect proliferation. Similarly, treatment with
EGF+BDNF did not alter proliferation compared
with untreated controls.
At 1 and 2 weeks of culture, cell proliferation was
modulated by growth factor treatments (Figures 3A
and 3B). While 10 ng/mL EGF induced proliferation,

BDNF treatment at 1 ng/mL or 100 ng/mL inhibited
proliferation. When combined, inhibition was
observed at 1 ng/mL and 100 ng/mL. In contrast,
proliferation in 4-week-old cultures was insensitive
to these growth factor treatments (Figure 3C).
Effects of EGF and BDNF on cultured taste cell
differentiation
Cultured taste cells treated with BrdU in the
presence of neurotrophic factors EGF, BDNF, or both
showed contrasting dose- and time-related effects
on the differentiation of cultured taste cells. Cells
were seeded onto collagen-coated coverslips and
maintained for 1, 2, or 4 weeks. Cells were treated
with 50 mM BrdU in the presence of EGF, BDNF,
and EGF+BDNF at 3 different concentrations (1,
10, and 100 ng/mL) for 5 days and fixed with 4%
paraformaldehyde. To determine the impact of these
treatments on differentiation and proliferation, cells
were stained with anti-gustducin and anti-BrdU
antibodies, respectively, and visualized by confocal
microscopy. The quantity of cells counted for each
condition (control versus treated) was similar, but
the number varied across groups (1 week versus
2 weeks versus 4 weeks). Therefore, in order to
standardize cell differentiation at the indicated time
points, the values were expressed as a percentage of
cells counted. Untreated cells (1 week) exhibited a
profile of proliferation and differentiation as follows:
23% BrdU − and gustducin −, 40% BrdU − and
gustducin +, 9% BrdU + and gustducin −, and 28%
BrdU + and gustducin + (Table 2A). No treatment
produced a higher proportion of gustducin + or
BrdU + cells when treated at 1 week. Treatment with
1 ng/mL of EGF did not show any effect on these
parameters, but BDNF treatment resulted in a higher
prevalence of BrdU − and gustducin + cells, with an
increase from 40% to 51%. In contrast, treatment
with 1 ng/mL EGF+BDNF resulted in an increase
in BrdU − and gustducin – cells from 23% to 41%
and a decrease in BrdU + and gustducin + cells from
28% to 9%. Treatment with 10 ng/mL EGF, BDNF, or
EGF+BDNF resulted in a moderate increase in BrdU
− and gustducin + cells from 40% in the control to
60%, 65%, and 65%, respectively. Treatment with
EGF, BDNF, and EGF+BDNF at 10 ng/mL reduced
the proportion of BrdU – and gustducin – cells
significantly (Table 2A). EGF did not alter the rate of
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Table 2. Effects of exogenous EGF and BDNF on taste cell differentiation and proliferation.
Dose
ng/mL

Age
(weeks)

Total cells
(n)

% both
negative

% BrdU +,
gustducin −

% BrdU –,
gustducin +

% both positive

Control

0

1

128

23

9

40

28

EGF

1

1

79

24

1

48

27

EGF

10

1

146

5

2

60

33

EGF

100

1

200

60

2

18

21

BDNF

1

1

129

13

3

51

33

BDNF

10

1

154

1

2

65

32

BDNF

100

1

114

29

11

44

17

EGF+BDNF

1

1

151

41

1

50

9

EGF+BDNF

10

1

206

1

2

65

32

EGF+BDNF

100

1

208

15

4

66

14

Control

0

2

32

31

12

44

13

EGF

1

2

15

67

7

13

13

EGF

10

2

61

2

3

61

34

EGF

100

2

38

11

5

58

26

BDNF

1

2

33

30

9

27

33

BDNF

10

2

44

2

0

66

32

BDNF

100

2

59

27

4

39

30

EGF+BDNF

1

2

19

47

5

26

21

EGF+BDNF

10

2

57

4

2

53

42

EGF+BDNF

100

2

64

17

2

40

48

Control

0

4

77

18

8

42

32

EGF

1

4

76

29

1

54

16

EGF

10

4

81

37

1

40

22

EGF

100

4

NA

NA

NA

NA

NA

BDNF

1

4

27

81

11

4

4

BDNF

10

4

22

14

14

42

30

BDNF

100

4

NA

NA

NA

NA

NA

EGF+BDNF

1

4

24

25

0

63

13

EGF+BDNF

10

4

57

26

9

55

11

EGF+BDNF

100

4

NA

NA

NA

NA

NA

Growth factor

A (1 week)

B (2 weeks)

C (4 weeks)
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BrdU + and gustducin + taste cells. EGF treatment at
100 ng/mL increased the prevalence of marker negative
cells from 23% to 60% and reduced that of BrdU – and
gustducin + cells from 40% to 18%, with no change in
the prevalence of cells labeled with both markers or
with BrdU alone. EGF at 100 ng/mL may have been
responsible for an increase in cellular proliferation but
may also have reduced the occurrence of BrdU – and
gustducin + cells. All treatments, with the exception of
100 ng/mL BDNF, reduced the proportion of BrdU +
and gustducin − cells.
At 2 weeks, untreated cells exhibited a profile of
proliferating and differentiated cells as follows (Table
2B): 31% BrdU – and gustducin –, 44% BrdU – and
gustducin +, 12% BrdU + and gustducin –, and 13%
BrdU + and gustducin +. While treatment with 1 ng/
mL of EGF and EGF+BDNF significantly increased
the proportion of gustducin – cells, treatment with
either 10 or 100 ng/mL of EGF shifted the labeling
pattern to a smaller number of nonimmunolabeled
cells with a higher proportion of gustducin + cells.
Cultured taste cells treated with 10 ng/mL of EGF,
BDNF, or EGF+BDNF yielded a significant increase
in gustducin + cells. Additionally, at 100 ng/mL, EGF,
BDNF, and EGF+BDNF increased the prevalence of
BrdU + and gustducin + cells (Table 2B).
Untreated cells grown for 4 weeks and treated with
BrdU for 5 days exhibited a profile of proliferating
and differentiated cells as follows (Table 2C): 18%
BrdU – and gustducin –, 42% BrdU – and gustducin
+, 8% BrdU + and gustducin –, and 32% BrdU +
and gustducin +. Treatment with EGF at 1 ng/mL
and EGF+BDNF at 1 and 10 ng/mL significantly
increased the proportion of gustducin + and BrdU
– cells at 4 weeks. BDNF treatment at 1 ng/mL
significantly reduced the prevalence of gustducin
+ cells and increased the frequency of unlabeled
cells. Moreover, EGF at 10 ng/mL induced a higher
proportion of BrdU – and gustducin – cells, while
EGF showed the opposite effect. The proportion of
BrdU + and gustducin – cells was higher when treated
with BDNF at either 1 or 10 ng/mL (Table 2C). These
data indicate that neurotrophic factors EGF and
BDNF influence the proliferation and differentiation
of cultured taste cells in a complex but apparently
interactive fashion, and that both concentration and
cell age modulate these effects.

Discussion
In contrast to the neuronal induction model (1,2), the
early specification model suggests that taste cells can
arise from the local ecto- or endodermal epithelium
of the oropharynx in the absence of innervation,
suggesting that taste cells may arise from multiple
progenitors (9-12,35,36). Neurotrophins might also
act as local trophic factors, inducing differentiation
of the taste buds by stimulating embryonic growth
of nerve fibers (37,38). However, the relationship
between trophic factors and the signaling
mechanisms governing differentiation/proliferation
and physiological maturation in taste cells is not
fully understood. This is due in part to the lack of
an in vitro model. In an in vitro model, taste cells
lose their innate components such as nerve fibers,
surrounding epithelial cells, and saliva. To determine
the role of neurotrophic factors on taste cell
proliferation and differentiation, we initially showed
the presence of EGFR and Trk-B, respectively, in rat
foliate papillae and cultured rat taste cells aged 9
days and 2 months, which is consistent with previous
in vivo data (17,24,31,39). The expression of BDNF
and its receptor Trk-B was found to be necessary
for proper morphogenesis of lingual gustatory
epithelia, taste bud formation during development,
and the regeneration of taste buds after denervation
(31,32,40,41). Overexpression of BDNF in mouse
tongue epithelium showed that most fungiform taste
buds failed to become innervated, and fungiform
papillae were small and disappeared postnatally.
These results suggest that BDNF, which normally
functions as a chemoattractant, has important
roles in regulating the development and spatial
patterning of fungiform papilla (42). EGFR and
Trk-B may have a role in taste cell regeneration.
It has been reported that BDNF in taste bud cells
may show its effect through Trk-B receptors on the
axons of nerves innervating taste buds and may act
on surrounding cells (31,43). Ookura et al. reported
that EGF stimulated the growth of cultured mouse
tongue epithelium (30). EGF is also involved in the
regulation of cell proliferation and differentiation
in a wide variety of tissues during various stages of
embryonic development (44-46). EGF stimulated
the proliferation of mouse tongue epithelial
cells (30). Our results are consistent with these
findings; EGF at 10 ng/mL significantly increased
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proliferation of 1- and 2-week-old cultured taste
cells but was ineffective in 4-week-old cells. In
contrast, BDNF inhibited cellular proliferation in
cells at all ages tested, and this inhibitory effect was
negated by concurrent treatment with the effective
concentration of EGF (10 ng/mL). Similar to EGF
alone, EGF+BDNF did not modify the proliferation
rates of 4-week-old cells.
To examine differentiation, we used the expression
of gustducin as a clear indication of phenotypic
similarity to at least one population of mature taste
cells in vivo. Additional studies are needed to examine
the influence of these neurotrophic factors on cells
that may express proteins indicative of other mature
taste cell types. Cultured taste cells treated with 50 mM
BrdU in the presence of EGF, BDNF, and EGF+BDNF
for 5 days indicated that EGF, BDNF, and their
combination at 10 ng/mL increased the prevalence
of gustducin immunoreactive cells in 1- and 2-weekold taste cell cultures but were ineffective in 4-weekold cultures. Although overexpression of BDNF
resulted in disruption of taste bud development and
numbers (47,48), EGFR/BDNF double-null mutant
mice showed a higher frequency of failed fungiform
taste bud differentiation (24). In another study, EGF
supplementation reversed the effects of the removal
of submandibular and sublingual salivary glands,
which resulted in the loss of fungiform taste buds and
changes in cellular morphology (26). Interestingly,

no treatment produced any significant change in
cultured taste cell differentiation and proliferation
in 4-week-old cultured rat taste cells. Presumably, in
cultures of this age, the number of cells expressing
receptors for these neurotrophins is insufficient.
In conclusion, expression of receptors for
2 neurotrophic factors implicated in taste bud
development and maintenance in our mediumterm culture model facilitates the study of the role of
these factors in the molecular processes underlying
proliferation and differentiation of taste receptor
cells. Here we showed that exogenous EGF and
BDNF at certain concentrations affect proliferation
and apparent maturation of cultured cells, based
on expression of a prominent and specific taste cell
marker, gustducin. This work lays the foundation for
future studies to examine the mechanisms controlling
proliferation and regeneration of cultured taste cells
and may provide new insights for future in vivo
therapeutic experiments.
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